Toxicity limits potential for cheaper prostate cancer treatment

Stereotactic body radiotherapy for prostate cancer led to significantly lower initial cost of care versus intensity-modulated radiotherapy, but increased toxicity offset most of the savings, a review of 4,000 cases showed.

MedPage Today